Concepedia

Alex Chehrazi‐Raffle

AC

14

Publications

767

Citations

12

H-Index

2015

Active since

Affiliations

City of Hope(Current)

Yale University

City Of Hope National Medical Center

Translational Genomics Research Institute

Huntsman Cancer Institute

Alex Chehrazi‐Raffle is an author at City of Hope specializing in medicine, urology, and immunology.

ORCID

Top concepts

Publications per year

2015–2024

14

Publications

14

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot et al. · Nature Medicine · 2022 · 427 citations · Full text

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Hedyeh Ebrahimi, Nazlı Dizman, Luís Meza et al. · Nature Medicine · 2024 · 64 citations · Full text

Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study

Toni K. Choueiri, Laurence Albigès, Philippe Barthélémy et al. · The Lancet · 2024 · 54 citations · Full text

, , +8

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

Alex Chehrazi‐Raffle, Luís Meza, Marice Alcantara et al. · Journal for ImmunoTherapy of Cancer · 2021 · 37 citations · Full text

Toxoplasma gondii Serology and Outcomes After Heart Transplantation: Contention in the Literature

Alex Chehrazi‐Raffle, Minh B. Luu, Zhenhua Yu et al. · Transplantation Proceedings · 2015 · 25 citations

, , +2

Rows per page

1–5 of 14